20 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34073371 | TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer. | 2021 May 26 | 1 |
2 | 31120927 | Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. | 2019 | 1 |
3 | 27375289 | COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR. | 2016 Jul 4 | 2 |
4 | 24563328 | Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance. | 2014 Apr | 1 |
5 | 22249258 | Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells. | 2012 Oct 4 | 2 |
6 | 18768663 | Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells. | 2008 Nov | 1 |
7 | 16195251 | Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor. | 2006 Feb | 1 |
8 | 15802375 | Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. | 2005 Jun | 7 |
9 | 12482846 | Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. | 2003 Feb 28 | 1 |
10 | 12684393 | Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. | 2003 Apr | 2 |
11 | 12730327 | Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor. | 2003 Aug | 4 |
12 | 12738788 | Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells. | 2003 Jul 18 | 1 |
13 | 11818500 | TR surfaces and conformations required to bind nuclear receptor corepressor. | 2002 Feb | 1 |
14 | 12145334 | Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. | 2002 Aug | 3 |
15 | 11553641 | The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes. | 2001 Nov 16 | 3 |
16 | 11916237 | Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. | 2001 Dec | 1 |
17 | 11059787 | Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. | 2000 Oct 15 | 1 |
18 | 11108862 | Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer. | 2000 Oct-Nov | 1 |
19 | 11162933 | Thoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring? | 2000 Nov 30 | 1 |
20 | 9501191 | Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. | 1998 Mar 17 | 2 |